Tenovin-1
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
| CAS NO: | 380315-80-0 |
| 规格: | ≥98% |
包装与价格：
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 1g | 电议 |
产品介绍
理化性质和储存条件
| Molecular Weight (MW) | 369.48 |
|---|
| Formula | C20H23N3O2S |
|---|
| CAS No. | 380315-80-0 |
|---|
| Storage | -20℃ for 3 years in powder form |
|---|
| -80℃ for 2 years in solvent |
| Solubility (In vitro) | DMSO: 74 mg/mL (200.28 mM) |
|---|
| Water:<1 mg/mL (slightly soluble or insoluble) |
| Ethanol:<1 mg/mL |
| Solubility (In vivo) | 15% Captisol: 15 mg/mL |
|---|
| Synonyms | Tenovin-1; Tenovin1; Tenovin 1 |
|---|
实验参考方法
| General | Initial in vivo experiments indicated that tenovin-1 impairs the growth of BL2-derived tumor xenografts. |
|---|
| Animal model | Female SCID mice injected subcutaneously with ARN8 cells suspended in matrigel. |
|---|
| Formulation | Formulated in 70% cyclodextrin |
|---|
| Dosages | 92.5 mg/kg |
|---|
| Administration | i.p. |
|---|
| References | [1] Lain S, et al. Cancer Cell, 2008, 13(5), 454-463. |
|---|
m.cnreagent.com
